/ en Tue, 14 Apr 26 15:20:04 -0400 /news/cancer-dependency-map-consortium-launches-phase-3-accelerate-next-generation-therapeutics <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Tue, 14 Apr 2026 19:20:04 +0000 kzusi@broadinstitute.org 5560381 at /news/leukemia-cells-use-sugar-coated-protein-hide-immune-system <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Thu, 09 Apr 2026 18:00:36 +0000 Corie Lok 5560351 at /news/high-fat-diets-make-liver-cells-more-likely-become-cancerous <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Mon, 22 Dec 2025 16:05:17 +0000 tulrich@broadinstitute.org 5559951 at /news/fda-approves-first-cancer-drug-based-broad-institute-science <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Thu, 20 Nov 2025 14:50:31 +0000 kzusi@broadinstitute.org 5559731 at /news/how-academic-industry-alliance-reshaping-way-research-can-lead-new-medicines <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Thu, 20 Nov 2025 10:00:00 +0000 leah@broadinstitute.org 5559726 at /news/pioneering-effort-patient-partnered-cancer-research-enters-new-phase <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Wed, 08 Oct 2025 19:45:02 +0000 leah@broadinstitute.org 5559451 at /news/study-identifies-genetic-targets-could-improve-car-t-therapies <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Wed, 24 Sep 2025 15:01:58 +0000 tulrich@broadinstitute.org 5559411 at /news/new-ai-based-diagnostic-tool-uses-epigenomics-accelerate-acute-leukemia-diagnosis <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Mon, 22 Sep 2025 14:00:11 +0000 tulrich@broadinstitute.org 5559416 at /news/breast-cancer-therapy-can-raise-uterine-cancer-risk-through-unique-mechanism <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Fri, 22 Aug 2025 14:01:54 +0000 tulrich@broadinstitute.org 5559301 at /news/blood-based-test-provides-new-diagnostic-approach-multiple-myeloma <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"> <span>By Karen Zusi-Tran</span> </span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" class="datetime">April 14, 2026</time> </span> <div class="hero-section container"> <div class="hero-section__row row"> <div class="hero-section__content hero-section__content_left col-6"> <div class="hero-section__breadcrumbs"> <div class="block block-system block-system-breadcrumb-block"> <nav class="breadcrumb" role="navigation" aria-labelledby="system-breadcrumb"> <h2 id="system-breadcrumb" class="visually-hidden">Breadcrumb</h2> <ol> <li> <a href="/">Home</a> </li> <li> <a href="/news">News</a> </li> </ol> </nav> </div> </div> <div class="hero-section__title"> <div class="block block-layout-builder block-field-blocknodelong-storytitle"> <span class="field field--name-title field--type-string field--label-hidden"><h1>Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics</h1> </span> </div> </div> <div class="hero-section__description"> <div class="block block-layout-builder block-field-blocknodelong-storybody"> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.</p> </div> </div> </div> <div class="hero-section__author"> <div class="block block-layout-builder block-extra-field-blocknodelong-storyextra-field-author-custom"> By Ó³»­´«Ã½ Communications </div> </div> <div class="hero-section__date"> <div class="block block-layout-builder block-field-blocknodelong-storycreated"> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2026-04-14T15:20:04-04:00" title="Tuesday, April 14, 2026 - 15:20" class="datetime">April 14, 2026</time> </span> </div> </div> </div> <div class="hero-section__right col-6"> <div class="hero-section__image"> <div class="block block-layout-builder block-field-blocknodelong-storyfield-image"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"> <article class="media media--type-image media--view-mode-multiple-content-types-header"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1921px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop_xl/public/longstory/DepMapConsortium_newsStory.png?itok=P_ozJJaT 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="754" height="503"/> <source srcset="/files/styles/multiple_ct_header_desktop/public/longstory/DepMapConsortium_newsStory.png?itok=dpu0I1Df 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="736" height="520"/> <source srcset="/files/styles/multiple_ct_header_laptop/public/longstory/DepMapConsortium_newsStory.png?itok=46QqQq89 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="641" height="451"/> <source srcset="/files/styles/multiple_ct_header_tablet/public/longstory/DepMapConsortium_newsStory.png?itok=DwcjzU9J 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="706" height="417"/> <source srcset="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU 1x" media="all and (max-width: 539px)" type="image/png" width="499" height="294"/> <img loading="eager" width="499" height="294" src="/files/styles/multiple_ct_header_phone/public/longstory/DepMapConsortium_newsStory.png?itok=bwVKblcU" alt="Dependency Map Consortium logo" title="Dependency Map Consortium logo" typeof="foaf:Image" /> </picture> </div> <div class="media-caption"> <div class="media-caption__description"> Dependency Map Consortium logo </div> </div> </article> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block block-better-social-sharing-buttons block-social-sharing-buttons-block"> <div style="display: none"><link rel="preload" href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg" as="image" type="image/svg+xml" crossorigin="anonymous" /></div> <div class="social-sharing-buttons"> <a href="https://www.facebook.com/sharer/sharer.php?u=/taxonomy/term/612/feed&title=" target="_blank" title="Share to Facebook" aria-label="Share to Facebook" class="social-sharing-buttons-button share-facebook" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#facebook" /> </svg> </a> <a href="https://twitter.com/intent/tweet?text=+/taxonomy/term/612/feed" target="_blank" title="Share to X" aria-label="Share to X" class="social-sharing-buttons-button share-x" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#x" /> </svg> </a> <a href="mailto:?subject=&body=/taxonomy/term/612/feed" title="Share to Email" aria-label="Share to Email" class="social-sharing-buttons-button share-email" target="_blank" rel="noopener"> <svg aria-hidden="true" width="32px" height="32px" style="border-radius:100%;"> <use href="/modules/contrib/better_social_sharing_buttons/assets/dist/sprites/social-icons--no-color.svg#email" /> </svg> </a> </div> </div> <div class="block block-layout-builder block-field-blocknodelong-storyfield-content-paragraphs"> <div class="field field--name-field-content-paragraphs field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--text-with-sidebar text-with-sidebar"> <div class="field field--name-field-sidebar field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--sidebar-articles sidebar-articles"> <div class="sidebar-articles__col"> <div class="clearfix text-formatted field field--name-field-heading field--type-text field--label-hidden field__item"><p>Related News</p> </div> <div class="field field--name-field-content-reference field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><article about="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=uPuti4Wp 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=apih6NVr 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=7mRZHCLe 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/longstory/DepMapConsortium_newsStory%20%281%29_0.png?h=f7d99906&itok=PWID5EAK" alt="Cancer Dependency Map Consortium logo" title="Cancer Dependency Map Consortium logo" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities</span> </a> </div> </article> </div> <div class="field__item"><article about="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node"> <div class="field field--name-field-image field--type-entity-reference field--label-hidden field__item"><article class="media media--type-image media--view-mode-multiple-ct-sidebar-link-with-image"> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies"><picture> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1921px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop_xl/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=G1-QX83Z 1x" media="all and (min-width: 1601px) and (max-width: 1920px)" type="image/png" width="104" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 1340px) and (max-width: 1600px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_desktop/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=_Bu-j1hZ 1x" media="all and (min-width: 800px) and (max-width: 1339px)" type="image/png" width="87" height="104"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_tablet/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=zKkSuqkh 1x" media="all and (min-width: 540px) and (max-width: 799px)" type="image/png" width="285" height="186"/> <source srcset="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm 1x" media="all and (max-width: 539px)" type="image/png" width="220" height="186"/> <img loading="eager" width="220" height="186" src="/files/styles/multiple_ct_sidebar_link_with_image_phone/public/news/images/2019/DepMapConsortium_newsStory.png?h=d3e04ee7&itok=kpBbC0lm" alt="" typeof="foaf:Image" /> </picture></a> </div> </article> </div> <div class="node__content"> <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" class="node__title"><span class="field field--name-title field--type-string field--label-hidden">Ó³»­´«Ã½ launches academic-industrial consortium for cancer dependency studies</span> </a> </div> </article> </div> </div> </div> </div> </div> </div> <div class="clearfix text-formatted field field--name-field-text field--type-text-long field--label-hidden field__item"><p dir="ltr">The Ó³»­´«Ã½â€™s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. <a href="/news/broad-institute-launches-academic-industrial-consortium-cancer-dependency-studies" target="_blank">Launched in late 2018</a>, the DMC is entering its third phase, building on years of foundational research to accelerate the discovery and understanding of novel oncology targets and biomarkers for the next generation of cancer therapies.</p> <p dir="ltr">The DMC supports the generation of high-quality datasets and exploratory tools that have systematically driven the discovery of genetic and chemical vulnerabilities in cancer. The consortium pioneers and scales new technologies, including advanced cancer models, functional genomics approaches, large-scale drug sensitivity screening through PRISM, and emerging multi-omics and single-cell approaches. The DMC also leads in the development of dependency analytics and software. </p> <p dir="ltr">"We have reached a pivotal moment where we can significantly accelerate cancer precision medicine," said <a target="_blank" href="/bios/william-sellers">William Sellers</a>, core institute member at the Ó³»­´«Ã½ and director of the institute’s <a target="_blank" href="/cancer">Cancer Program</a>. "DMC 3.0 is designed to bridge the gap between functional genomics and therapeutics by systematically addressing resistance and leveraging new modalities like cell surface targets, to define how we can selectively kill cancer cells."</p> <p dir="ltr">The DMC is powered by a robust alliance of industry leaders, including:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="eae0f574ecf3e8660e2fcf5c2087754a5">AbbVie</li> <li dir="ltr" aria-level="1" data-list-item-id="e6287d96497603e3944884bd57faf9b0c">Amgen</li> <li dir="ltr" aria-level="1" data-list-item-id="ed3a34ac24af2235713f6cd36d670d9eb">Bayer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb97bb430912dce47b5267d020ba90bca">Bristol Myers Squibb</li> <li dir="ltr" aria-level="1" data-list-item-id="ebe66de788bc80a401789a4a29cbef20b">Boehringer Ingelheim</li> <li dir="ltr" aria-level="1" data-list-item-id="e096b2028da0adc7910831235f117f9ed">Deciphera, a member of Ono Pharma</li> <li dir="ltr" aria-level="1" data-list-item-id="e18453e2e0ee6cf12f38f7f80f21d4c06">Exelixis</li> <li dir="ltr" aria-level="1" data-list-item-id="e4e8bc765918c1bbec900794d1470ffb0">Genentech, a member of the Roche Group</li> <li dir="ltr" aria-level="1" data-list-item-id="ebca379957ea70ebe43ae27efd2f71c90">Gilead</li> <li dir="ltr" aria-level="1" data-list-item-id="ea04e4ce2957e0910eff4a228e861c037">GSK</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0046027c8bff4d2b0b61e019ac4bd3e">IDEAYA Biosciences</li> <li dir="ltr" aria-level="1" data-list-item-id="e1c2a6ea5a3096d5ad73986bc259bf228">Incyte</li> <li dir="ltr" aria-level="1" data-list-item-id="e654064c240d9fde5097218350390843e">Johnson & Johnson</li> <li dir="ltr" aria-level="1" data-list-item-id="ecbdce829ff6f1a7afe3d54f86645eb2e">Eli Lilly and Company</li> <li dir="ltr" aria-level="1" data-list-item-id="ee977793d92d9486fedefc64e65a50dde">Merck (known as MSD outside of the United States and Canada)</li> <li dir="ltr" aria-level="1" data-list-item-id="e701cf6acae33676c52764881aa6d27ca">Novartis</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1ad073ac55058a63c12fee761af066b">Pfizer</li> <li dir="ltr" aria-level="1" data-list-item-id="eb5b534c31fd07b47cb2a14273c669f98">Pierre Fabre Laboratories</li> <li dir="ltr" aria-level="1" data-list-item-id="e80ce575cd0f83526d56ed5087fafaac5">Revolution Medicines</li> <li dir="ltr" aria-level="1" data-list-item-id="ec0e002677fada1f336ae5ee18ff06bdc">Roche</li> <li dir="ltr" aria-level="1" data-list-item-id="e4fde3e9eaf49d4a04648dc56e932b670">Servier</li> <li dir="ltr" aria-level="1" data-list-item-id="ee1a15457dc633cadc815362f8957fd6b">Takeda</li> </ul> <h2>A foundation of scale</h2> <p dir="ltr">The launch of this next phase follows the successful completion of <a href="/news/cancer-dependency-map-consortium-accelerates-research-tumor-vulnerabilities" target="_blank">DMC 2.0</a>, which dramatically expanded the Cancer Dependency Map (DepMap) resource. The cancer cell line collection grew to over 2,000 models across diverse human cancer subtypes, including 3D models such as organoids and spheroids. Using the PRISM platform, 400 compounds were screened across 900 cancer cell lines, and combinatorial screens were leveraged to unmask critical dependencies hidden due to paralog redundancy. The researchers also generated a variety of new multi-omics datasets and new analytical and software tools, aiding research toward the discovery of new predictive biomarkers.</p> <p dir="ltr">Notable targets identified through this work include the WRN helicase in MSI+ cancers and PRMT5 in MTAP/CDKN2A co-deleted cancers — both of which have led to therapeutic candidates tested in clinical trials. Most recently, the consortium identified the ribosomal rescue protein PELO as a vulnerability in chromosome 9p21-deleted or MSI cancers.</p> <p dir="ltr">"The Cancer Dependency Map Consortium at the Ó³»­´«Ã½ provides an indispensable atlas for next generation precision medicine," said Dale Porter, head of US research at Servier. "By systematically mapping the genetic and pharmacologic vulnerabilities of cancer — including inaccessible patient-derived models — the DMC has created a powerful engine for high-confidence target discovery and the identification of predictive biomarkers that ensure the right drugs reach the right patients. Furthermore, the integration of the PRISM screening platform is a game-changer. Its ability to evaluate hundreds of compounds across hundreds of diverse cell lines provides unprecedented speed and depth in drug discovery. At Servier, we are especially looking forward to how it will allow us to visualize the therapeutic potential of new leads and reference molecules."</p> <h2>Targeting resistance and new modalities</h2> <p dir="ltr">DMC 3.0 aims to support early discovery for newer therapeutic modalities and address the challenges of therapeutic resistance. Key focus areas for new data and software tools include:</p> <ul> <li dir="ltr" aria-level="1" data-list-item-id="e3b20edf5731532ec79d0b8f01b095657">Expanding multi-omics profiling with new Ó³»­´«Ã½ technologies to identify novel synthetic lethal targets and better define patient populations</li> <li dir="ltr" aria-level="1" data-list-item-id="eef4fc2e027b0d743f0c282b774bcd81d">Systematically cataloging novel and existing surface proteins to guide biologics and cell-based therapies</li> <li dir="ltr" aria-level="1" data-list-item-id="e32707eacd66d0a3a0e1d99ded49f75ae">Addressing resistance by mapping vulnerabilities in the resistance setting </li> <li dir="ltr" aria-level="1" data-list-item-id="e59f7e2dc479958a5f0d360abd7b23a8b">Integrating patient-derived data directly into the models to accelerate the path to therapeutics</li> <li dir="ltr" aria-level="1" data-list-item-id="ed099081cc038db1d17246dfbf48be90d">Using high-dimensional readouts to identify key targets that were previously missed </li> </ul> <p dir="ltr">Academic scientists, industry researchers, and biotech investors alike rely on this target discovery platform to de-risk drug development. The contributions of this program continue to propel new clinical programs and support the launch of new biotech companies.</p> <p dir="ltr">"The impact of the resource generated by the DMC is clear: It’s a catalyst for the entire oncology community," said <a target="_blank" href="/bios/francisca-vazquez">Francisca Vazquez</a>, director of the <a target="_blank" href="https://depmap.org/portal/home/#/">Cancer Dependency Map</a> at the Ó³»­´«Ã½. "In Phase 3, we are providing a roadmap for the next decade of precision medicine, moving the field beyond cataloging cancer’s weaknesses to enabling the development of next-generation, safer medicines."</p> </div> </div> </div> </div> </div> </div> </div> <div class="content-section container"> <div class="content-section__main"> <div class="block-node-broad-tags block block-layout-builder block-field-blocknodelong-storyfield-broad-tags"> <div class="block-node-broad-tags__row"> <div class="block-node-broad-tags__title">Tags:</div> <div class="field field--name-field-broad-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/broad-tags/cancer-program" hreflang="en">Cancer Program</a></div> <div class="field__item"><a href="/broad-tags/cancer-dependency-map" hreflang="en">Cancer Dependency Map</a></div> <div class="field__item"><a href="/broad-tags/cancer" hreflang="en">Cancer</a></div> </div> </div> </div> </div> </div> Fri, 08 Aug 2025 15:00:00 +0000 tulrich@broadinstitute.org 5559256 at